(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMENCEO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMENCEO

ST13

US500000079440399

Class

5

Filing

79440399

Registration

8340220

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

07/14/2026

Trademark type

Word

Nice classes

5

Filing date

11/12/2025

Registration date

07/14/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/14/2026

Last transaction

07/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

CH

Examiner

MCBRIDE, CAMERON L

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Novartis AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/14/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/14/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/26/2026

PUBO

PUBLISHED FOR OPPOSITION

05/26/2026

GPNX

NOTIFICATION PROCESSED BY IB

05/21/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/06/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/06/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/27/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/07/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/07/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/07/2026

RFNT

REFUSAL PROCESSED BY IB

03/26/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/25/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/25/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/25/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/25/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/25/2026

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/12/2026

RFRR

REFUSAL PROCESSED BY MPU

03/12/2026

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/07/2026

CNRT

NON-FINAL ACTION WRITTEN

02/06/2026

DOCK

ASSIGNED TO EXAMINER

01/30/2026

MAFR

APPLICATION FILING RECEIPT MAILED

01/25/2026

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/25/2026

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/23/2026

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/01/2026

Continuous trademark protection

Get notified about every new filing that threatens IMENCEO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.